/ / Dyufaston: instruction and description

DUFASTON: instruction and description

Many women today facehormonal disorders. One of the most common of these is the lack of progesterone. This problem can lead to serious consequences, including infertility. The drug, which is now widely used to solve it, is djufaston. The instruction recommends its use in endometriosis, infertility, premenstrual syndrome, dysmenorrhea, irregular cycle, amenorrhea, uterine bleeding, habitual and threatening miscarriage. It is also used for hormonal therapy with estrogens.

The active ingredient dyufastone isdydrogesterone. It is very similar to progesterone for its pharmacological and chemical properties, as well as its molecular structure. For dydrogesterone, the side effects that occur with the use of androgenic progestogens are uncharacteristic, since this substance is not a derivative of testosterone.

Thermogenic, glucocorticoid, anabolic,androgenic and estrogenic activity is not possessed by djufaston. The description to it indicates that the drug does not affect the parameters of blood coagulability, carbohydrate metabolism and liver function. Duphaston affects the endometrium, reducing the risk of its hyperplasia and cancer, especially with an excess of estrogens. Its use is recommended for a lack of progesterone.

Many patients are interested in whether it is possiblePregnancy if they take duhfaston. The instruction to the drug says that it does not have a contraceptive effect. Dydrogesterone provides a therapeutic effect without suppressing ovulation. Preservation of pregnancy and conception is possible during treatment.

The drug penetrates into the milk, so breastfeeding is unacceptable during the therapy with Duphaston. The instruction to him warns about the following side effects:

  • peripheral edema;
  • itching and rash;
  • abdominal pain, jaundice, malaise, weakness due to impaired liver function;
  • urticaria, angioedema;
  • migraine;
  • hemolytic anemia;
  • breast sensitivity.

They are rare. Occasionally, uterine bleeding occurs. They can be prevented by increasing the dose. Contraindication to admission - individual intolerance.

The scheme of the drug depends on the diseaseand the cycle of the patient. With its standard length, a woman stops taking dyufaston on day 25, and monthly doses come in 2-3 days after this. The beginning of the drug depends on the disease.

So, from the 5th day of the cycle, a pill is prescribed twice a day for dysmenorrhea and endometriosis. With the last disease, the reception can be continuous, and the number of mg per day increased to 30.

From the 11th day of the cycle, it is recommended to take dufastonewith amenorrhea, irregular cycle, premenstrual syndrome and for the prevention of uterine bleeding twice a day on a pill. With infertility, the reception starts from the 14th day.

To stop uterine bleeding appoint totablet twice a day for a week. In case of a threatening miscarriage, it is recommended to take 40 mg of dufastone once, then to disappear the symptoms every 8 hours on a pill. With a habitual miscarriage it is taken twice a day for 10 mg before the 20th week of pregnancy, then gradually reduce the dose.

Dufaston does not affect the temperature. Therefore, when used, ovulation can be monitored by rectal measurement. The tablet contains 10 mg of the drug, in the package of 20 pieces.

So, djufaston, the instruction to which is obligatoryshould be read before its use, is used for diseases that occur when there is a shortage of progesterone. Among them, infertility, endometriosis, amenorrhea, dysmenorrhea, cycle disorders, miscarriages, premenstrual syndrome and uterine bleeding. The scheme of reception and its duration is selected by the doctor individually.

</ p>>
Read more: